Inventera Overview

  • Year Founded
  • 2018

Year Founded

  • Status
  • Public

  • Employees
  • 20

Employees

  • Stock Symbol
  • 0007J0

Stock Symbol

  • Investments
  • 1

Inventera General Information

Description

Developer of a biotech company designed to develop innovative imaging diagnostic contrast agents. The company's platform specialized in developing advanced magnetic resonance imaging contrast agents using patented technology, which utilizes a polysaccharide core and metal shell, its design aims to improve imaging resolution and biocompatibility, which could lead to significant advancements in medical imaging, providing clients with resolution magnetic resonance imaging contrast agents as well as computerized tomography and nuclear medicine contrast media.

Contact Information

Website
www.inventera.kr
Formerly Known As
Inventera Pharmaceuticals
Ownership Status
Publicly Held
Financing Status
Formerly VC-backed
Corporate Office
  • 2nd Floor
  • 111 Seocho-daero, Seocho-gu
  • Seoul
  • South Korea
+82
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Stock Exchange
KRX
Vertical(s)
Nanotechnology
Corporate Office
  • 2nd Floor
  • 111 Seocho-daero, Seocho-gu
  • Seoul
  • South Korea
+82

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Inventera Financials Summary

As of 31-Dec-2024, Inventera has a trailing 12-month revenue of null.

In Thousands,
USD 		TTM 31-Dec-2024 FY 2024 31-Dec-2024 FY 2023 31-Dec-2023 FY 2022 31-Dec-2022
EV 415 415 344 168
EBITDA (4,359) (4,359)
Total Assets 15,110 15,110 6,533 8,681
Total Debt 0 0 0 0
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Inventera Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA		 Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Inventera‘s full profile, request access.

Request a free trial

Inventera Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Inventera Investments (1)

Inventera’s most recent deal was a Later Stage VC with Light Pharmtech. The deal was made on 12-Sep-2022.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Light Pharmtech 12-Sep-2022 Later Stage VC Pharmaceuticals
To view Inventera’s complete investments history, request access »

Inventera FAQs

  • When was Inventera founded?

    Inventera was founded in 2018.

  • Where is Inventera headquartered?

    Inventera is headquartered in Seoul, South Korea.

  • What is the size of Inventera?

    Inventera has 20 total employees.

  • What industry is Inventera in?

    Inventera’s primary industry is Drug Discovery.

  • Is Inventera a private or public company?

    Inventera is a Public company.

  • What is Inventera’s stock symbol?

    The ticker symbol for Inventera is 0007J0.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process